Replies to post #104312 on NorthWest Biotherapeutics Inc (NWBO)

[Barunuuk]

Flipper, I don't argue that ICT-107 P2 enrolled rapid and pseudoprogressors, however, I truly doubt they randomized (meaning, they included them in the trial) many of these, particularly the rapid progressors. They enrolled ~278 patients, but only randomized 124 patients. That means there was some intensive screening there between enrolled and randomized patients.

Its on their website:

http://www.imuc.com/pipeline/ict-107